Agouron AGPH/3Q 8,436/16% (11,006)/(3,270) (1.04)/(0.45) 17,064/83% 104,656 10,571

Anergen ANRG/1Q 922/62% (1,531)/(1,863) (0.10)/(0.25) 1,895/-0% 9,653 14,984

Arris ARRS/1Q 5,044/30% (1,563)/(535) (0.15)/(0.06) 5,644/58% 66,383 10,404

Athena ATHN/1Q 14,777/25% (4,410)/(11,431) (0.16)/(0.50) 7,032/-19% 42,101 27,613

BioCryst BCRX/1Q 169/8% (1,913)/(2,908) (0.20)/(0.37) 1,552/-37% 17,387 9,621

Biogen BGEN/1Q 34,378/8% (3,658)/2,834 (0.10)/0.08 24,411/19% 293,432 35,600

Bio-Technology General BTGC/1Q 10,711/86% 926/402 0.02/0.01 3,104/9% NR 47,147

Cell Genesys CEGE/1Q 4,391/199% (3,123)/(5,389) (0.19)/(0.39) 6,689/9% 80,017 16,239

Centocor CNTO/1Q 21,882/-9% (9,698)/(8,242) (0.16)/(0.14) 12,548/-7% 251,491 59,944

COR Therapeutics* CORR/1Q 2,531/ (11,490)/(8,664) (0.59)/(0.45) 13,141/68% 70,330 19,464

Cortech CRTQ/1Q 3,877/167% (561)/(5,761) (0.03)/(0.33) 3,430/-42% 22,796 17,948

Cortex CORX/3Q 0/0% (1,145)/(1,195) (0.18)/(0.20) 761/-11% 4,692 6,537

Corvas CVAS/1Q 2,187/103% (631)/(1,649) (0.05)/(0.18) 2,299/2% 24,908 11,507

CytoTherapeutics CTII/1Q 1,664/-74% (2,996)/1,873 (0.20)/0.17 3,905/14% 39,551 15,274

DNX DNXX/1Q 7,120/2% 18/(1,407) 0.00/(0.16) 104/-64% 20,854 9,142

Genelabs Technologies GNLB/1Q 2,955/-38% (3,017)/(2,395) (0.09)/(0.10) 2,445/-16% 26,900 33,712

Genetics Institute GENIZ/1Q 71,848/39% 22,328/5,699 0.74/0.21 31,606/17% 276,951 30,152

Human Genome Sciences* HGSI/1Q 13,934/ 4,287/(6,000) 0.22/(0.40) 9,012/25% 128,532 19,489

Hybridon HYBN/1Q 554/77% (9,287)/(7,946) (0.41)/(0.56) 7,383/11% 44,524 22,708

ImmuCell ICCC/1Q 1,416/-4% (12)/102 0.00/0.04 501/34% 1,143 2,292

ImmuLogic IMUL/1Q 625/-89% (5,679)/(1,400) (0.28)/(0.09) 6,107/-3% 56,426 20,172

Immune Response** IMNR/1Q 0/-100% (5,501)/(4,501) (0.33)/(0.27) 5,477/31% 38,997 16,800

Incyte INCY/1Q 5,583/277% (2,058)/(1,964) (0.21)/(0.25) 7,371/127% 49,006 9,830

Isis ISIP/1Q 6,409/107% (5,053)/(5,869) (0.20)/(0.30) 9,816/32% 75,000 25,348

Matrix MATX/1Q 0/0% (7,078)/(5,284) (0.42)/(0.49) 5,700/29% 69,559 16,941

Medarex MEDX/1Q 365/35% (1,686)/(1,688) (0.14)/(0.19) NR/NR 14,074 11,859

MedImmune MEDI/1Q 11,434/93% (1,568)/(5,466) (0.08)/(0.37) 5,393/-18% 92,340 19,294

Neoprobe*** NEOP/1Q 196/-28% (3,550)/(2,541) (0.20)/(0.21) NR/NR 14,893 17,427

Neurobiological Tech. NTII/3Q 116/-29% (1,331)/(1,385) (0.24)/(0.35) 1,032/-12% 12,241 5,536

Procept PRCT/1Q 552/-58% (3,082)/(2,842) (0.40)/(0.45) 2,828/-11% 4,035 7,761

ProCyte PRCY/1Q 1,689/31% (1,422)/(1,570) (0.11)/(0.12) 1,747/-8% 34,746 13,153

SciClone* SCLN/1Q 126/ (3,739)/(3,569) (0.22)/(0.21) 2,535/9% 45,000 17,052

Scios SCIO/1Q 11,484/-16% (7,417)/(6,627) (0.21)/(0.19) 8,666/24% 27,366 35,891

Sequana SQNA/1Q 1,886/152% (3,622)/(2,282) (0.42)/(0.43) 5,079/107% 68,853 NR

Sequus SEQU/1Q 4,494/404% (5,777)/(9,165) (0.21)/(0.48) 5,929/8% 45,007 27,911

Shaman* SHMN/1Q 500/ (5,011)/(4,483) (0.38)/(0.34) 4,799/24% 21,844 13,334

Somatix SOMA/3Q 0/0% (5,508)/(19,476) (0.24)/(1.15) 4,656/-3% 9,677 23,043

Sugen SUGN/1Q 3,427/-1% (1,418)/(4,006) (0.16)/(0.38) 4,995/-24% 46,604 10,473

Targeted Genetics TGEN/1Q 183/39% (2,892)/(2,622) (0.23)/(0.29) 2,366/20% 11,878 12,343

The Liposome Co. LIPO/1Q 12,409/570% (4,091)/(10,333) (0.16)/(0.49) 7,006/-24% 43,744 30,191

U.S. Bioscience UBS/1Q 3,827/45% (3,433)/(4,156) (0.08)/(0.10) 2,765/-1% 46,773 42,826

Vertex VRTX/1Q 3,751/-41% (7,468)/(4,703) (0.43)/(0.27) 9,337/-0% 77,256 17,331

Vical VICL/1Q 520/-47% (1,905)/(1,517) (0.12)/(0.12) 2,380/14% 49,847 15,373

NOTES:

All NASDAQ except U.S. Bioscience (AMEX); for quarters ending3/31/96.

NR = Not reported

* Had no revenue in comparable 1995 quarter.

** Immune Response had revenues of $1.3M in comparable1995 quarter.

*** Neoprobe's cash position does not include $30.3M inproceeds from 4/96 offering.

(c) 1997 American Health Consultants. All rights reserved.